Similar Papers

Paper Title
Journal
Date
Author
Characteristics of COVID-19 disease in multiple sclerosis patients
Mahdi Barzegar ... Reza Vosoughi
Multiple Sclerosis and Related Disorders | VOL. 45
Mahdi Barzegar, et. al.Mahdi Barzegar ... Reza Vosoughi
08 Jun 2020
Lymphocyte calcium influx characteristics and its modulation by Kv1.3 and IKCa1 potassium channel inhibitors in multiple sclerosis
...
F1000Research | VOL. 2
, et. al. ...
06 Jul 2011
Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year.
Kristen M Johnson ... John J Ko
Journal of Managed Care & Specialty Pharmacy | VOL. 23
Kristen M Johnson, et. al.Kristen M Johnson ... John J Ko
01 Aug 2017
The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
Irene Eriksson ... Fredrik Piehl
European Journal of Clinical Pharmacology | VOL. 74
Irene Eriksson, et. al.Irene Eriksson ... Fredrik Piehl
10 Feb 2018
View more papers

More From: Farmeconomia. Health economics and therapeutic pathways

Paper Title
Journal
Date
Author
Therapeutic Journey and Economic Burden of Patients with Myasthenia Gravis in Italy: Results of a Real-World Analysis
Valentina Perrone ... Luca Degli Esposti
Farmeconomia. Health economics and therapeutic pathways | VOL. -
Valentina Perrone, et. al.Valentina Perrone ... Luca Degli Esposti
31 Jan 2025
Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis
Lorenzo Mantovani ... Luca Prosperini
Farmeconomia. Health economics and therapeutic pathways | VOL. 25
Lorenzo Mantovani, et. al.Lorenzo Mantovani ... Luca Prosperini
17 Dec 2024
Decatecholaminization of Septic Shock Patients in Intensive Care Unit: an Economic Assessment in the Italian Setting
Alfredo Del Gaudio ... Luigi Tritapepe
Farmeconomia. Health economics and therapeutic pathways | VOL. 25
Alfredo Del Gaudio, et. al.Alfredo Del Gaudio ... Luigi Tritapepe
19 Nov 2024
Enhanced Influenza Vaccines Under Review by the ECDC and the Latest Scientific Literature
Pier Luigi Lopalco
Farmeconomia. Health economics and therapeutic pathways | VOL. 25
Pier Luigi LopalcoPier Luigi Lopalco
22 Oct 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.